Life style and Parkinson's disease.

Caffeine Exercise Humans Life Style Parkinson Disease Parkinsonian Disorders
Alcohol Caffeine Environment Life style Nicotine Parkinson’s disease Physical activity

Journal

Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341

Informations de publication

Date de publication:
09 2022
Historique:
received: 25 03 2022
accepted: 27 04 2022
pubmed: 24 5 2022
medline: 14 9 2022
entrez: 23 5 2022
Statut: ppublish

Résumé

The question whether life style may impair the advent or course of the disease in patients with Parkinsonism is of great importance for patients and physicians alike. We present here comprehensive information on the influence of the environment, diet (especially caffeine, nicotine, alcohol, chocolate and dairy products), physical activity and sleep on risk and course of Parkinson's disease.

Identifiants

DOI: 10.1007/s00702-022-02509-1 PMID: 35606622 PMC: PMC9463300
pubmed: 35606622
doi: 10.1007/s00702-022-02509-1
pii: 10.1007/s00702-022-02509-1
pmc: PMC9463300
doi:

Substances chimiques

Caffeine 3G6A5W338E

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1235-1245

Informations de copyright

© 2022. The Author(s).

Références

Arch Neurol. 1992 Apr;49(4):360-5
pubmed: 1558515
PLoS One. 2013 Jun 19;8(6):e66452
pubmed: 23840473
Ann Neurol. 2003 Aug;54(2):170-5
pubmed: 12891669
Cell Mol Neurobiol. 2009 Dec;29(8):1169-80
pubmed: 19466539
Biochem Pharmacol. 2009 Oct 1;78(7):677-85
pubmed: 19433069
Neurology. 2020 May 19;94(20):e2132-e2138
pubmed: 32371450
Neurology. 2018 Feb 13;90(7):e583-e592
pubmed: 29352099
Mov Disord. 2011 Nov;26(13):2427-31
pubmed: 21953603
Mov Disord. 2013 Mar;28(3):380-3
pubmed: 23339054
Am J Epidemiol. 2007 May 1;165(9):998-1006
pubmed: 17272289
Int J Epidemiol. 2019 Jun 1;48(3):912-925
pubmed: 30462234
Mov Disord. 2012 Jul;27(8):980-7
pubmed: 22714720
Front Public Health. 2020 Apr 07;8:91
pubmed: 32318533
Toxics. 2018 Nov 02;6(4):
pubmed: 30400192
Neurology. 2006 Dec 12;67(11):1955-9
pubmed: 17159100
Brain. 2019 Jan 1;143(1):249-265
pubmed: 31816026
Biomed Pharmacother. 2017 Jun;90:638-649
pubmed: 28412655
Ann Rheum Dis. 2012 Jun;71(6):929-34
pubmed: 22275296
Neurology. 2005 Mar 22;64(6):1047-51
pubmed: 15781824
J Neurol Neurosurg Psychiatry. 2006 Dec;77(12):1318-22
pubmed: 16926235
Environ Int. 2017 Oct;107:100-110
pubmed: 28704700
Fukuoka Igaku Zasshi. 2011 Aug;102(8):254-65
pubmed: 21966751
Parkinsonism Relat Disord. 2020 Nov;80 Suppl 1:S45-S53
pubmed: 33349580
Neurology. 2002 Feb 26;58(4):581-8
pubmed: 11865136
Neurology. 2005 Feb 22;64(4):664-9
pubmed: 15728289
J Neurol. 2004 Oct;251 Suppl 7:vII14-7
pubmed: 15505749
Mol Nutr Food Res. 2011 Feb;55(2):198-208
pubmed: 20669245
Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S34-S42
pubmed: 30241099
Int J Hyg Environ Health. 2019 Apr;222(3):402-409
pubmed: 30606679
J Neural Transm (Vienna). 2015 Feb;122(2):253-6
pubmed: 24872078
J Parkinsons Dis. 2020;10(2):505-510
pubmed: 32250320
Lancet Neurol. 2016 Nov;15(12):1257-1272
pubmed: 27751556
Am J Epidemiol. 2006 Apr 15;163(8):726-30
pubmed: 16495472
Neurology. 2010 Mar 16;74(11):878-84
pubmed: 20220126
Br J Nutr. 2013 Jan 28;109(2):329-37
pubmed: 22716925
Genome Med. 2017 Apr 28;9(1):39
pubmed: 28449715
Regul Toxicol Pharmacol. 2018 Jul;96:57-63
pubmed: 29729297
Eur J Epidemiol. 2013 Jan;28(1):67-77
pubmed: 23377703
BMJ. 2017 Jun 6;357:j2353
pubmed: 28588063
Occup Environ Med. 2020 Dec 15;:
pubmed: 33323454
Mov Disord. 1999 Nov;14(6):1011-3
pubmed: 10584678
Neuroepidemiology. 2001 May;20(2):118-24
pubmed: 11359079
Neurol Sci. 2016 May;37(5):743-7
pubmed: 26753800
JAMA Neurol. 2021 Dec 1;78(12):1446-1453
pubmed: 34724534
Nutrients. 2021 Nov 07;13(11):
pubmed: 34836224
Int J Environ Res Public Health. 2016 Sep 03;13(9):
pubmed: 27598189
BMC Neurol. 2013 Dec 05;13:190
pubmed: 24314068
Ann Neurol. 2002 Dec;52(6):793-801
pubmed: 12447934
Eur J Epidemiol. 2014 Sep;29(9):613-9
pubmed: 24894826
Environ Sci Pollut Res Int. 2018 Feb;25(4):3211-3232
pubmed: 29230653
J Sleep Res. 2017 Oct;26(5):623-628
pubmed: 28470725
Neuromolecular Med. 2009;11(4):239-51
pubmed: 19669606
J Neurol. 2009 Mar;256(3):488-92
pubmed: 19277767
Parkinsonism Relat Disord. 2016 Feb;23:1-9
pubmed: 26739246
Neurotox Res. 2018 Aug;34(2):250-262
pubmed: 29520721
Arch Neurol. 2007 Jul;64(7):990-7
pubmed: 17620489
J Parkinsons Dis. 2019;9(2):413-426
pubmed: 30958316
Nutrients. 2019 Aug 14;11(8):
pubmed: 31416163
Mov Disord. 2020 Mar;35(3):443-449
pubmed: 31769113
ScientificWorldJournal. 2012;2012:923464
pubmed: 22448141
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):31-9
pubmed: 14687854
PLoS Med. 2018 Aug 21;15(8):e1002640
pubmed: 30130376
JAMA Netw Open. 2018 Sep 7;1(5):e182421
pubmed: 30646166
Brain. 2019 Jul 1;142(7):2013-2022
pubmed: 31038176
Nutr Res Rev. 2011 Dec;24(2):244-75
pubmed: 22153059
Nutrients. 2020 Sep 10;12(9):
pubmed: 32927800
Mov Disord. 2008 Jun 15;23(8):1174-83
pubmed: 18442112
Oxid Med Cell Longev. 2017;2017:6405278
pubmed: 29081890
J Alzheimers Dis. 2010;20 Suppl 1:S221-38
pubmed: 20182023
Nutrients. 2021 Sep 19;13(9):
pubmed: 34579146
Eur J Epidemiol. 2014 Apr;29(4):285-92
pubmed: 24633681
Int J Mol Sci. 2020 Oct 10;21(20):
pubmed: 33050475
Psychopharmacology (Berl). 1995 Jan;117(2):253-6
pubmed: 7753975
Nutrients. 2017 Dec 02;9(12):
pubmed: 29207471
Mov Disord. 2012 Feb;27(2):293-6
pubmed: 22095755
Ann Neurol. 2002 Sep;52(3):276-84
pubmed: 12205639
Annu Rev Neurosci. 2011;34:105-30
pubmed: 21438686
Neurology. 2001 Sep 25;57(6):1032-5
pubmed: 11571330
Mov Disord. 2020 Jul;35(7):1258-1263
pubmed: 32357270
Neurology. 2014 Oct 14;83(16):1396-402
pubmed: 25217056
Mov Disord. 2021 Jan;36(1):255-260
pubmed: 33078857
Am J Epidemiol. 2007 Sep 1;166(5):561-7
pubmed: 17584757
Presse Med. 2017 Mar;46(2 Pt 1):175-181
pubmed: 28189372
J Neurol. 2012 Nov;259(11):2447-51
pubmed: 22584952
Neurology. 2017 Jul 4;89(1):46-52
pubmed: 28596209
Exp Neurol. 2011 Apr;228(2):160-4
pubmed: 21211537
Neurology. 2010 Jul 27;75(4):341-8
pubmed: 20660864
Mov Disord. 2015 Nov;30(13):1854-6
pubmed: 26769461

Auteurs

Heinz Reichmann (H)

Department of Neurology, University Hospital Dresden, Fetscherstrasse 74, 01307, Dresden, Germany. Heinz.Reichmann@ukdd.de.

Ilona Csoti (I)

Fachklinik für Parkinson, Gertrudis Klinik Biskirchen, Karl-Ferdinand-Broll-Straße 2-4, 35638, Leun-Biskirchen, Germany.

Jiri Koschel (J)

Parkinson-Klinik, Ortenau GmbH & Co. KG, Kreuzbergstraße 12-16, 77709, Wolfach, Germany.

Stefan Lorenzl (S)

Neurologie und Palliative Care, Krankenhaus Agatharied, Norbert-Kerkel-Platz, 83734, Hausham, Germany.

Christoph Schrader (C)

Neurologische Klinik mit Klinischer Neurophysiologie OE 7210, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Juergen Winkler (J)

Zentrum für Bewegungserkrankungen, Molekulare Neurologie, Universitätsklinikum Erlangen, Schwabachanlage 6, 91054, Erlangen, Germany.

Ullrich Wüllner (U)

Department of Neurology, University Clinic Bonn and German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Purines › Purinones › Xanthines › Caféine › Life style and Parkinson's disease.
questionsmedicales.fr › Activités humaines › Exercice physique › Life style and Parkinson's disease.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Life style and Parkinson's disease.
questionsmedicales.fr › Comportement et mécanismes comportementaux › Mode de vie › Life style and Parkinson's disease.
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Maladie de Parkinson › Life style and Parkinson's disease.
questionsmedicales.fr › Maladies du système nerveux › Maladies du système nerveux central › Troubles de la motricité › Syndromes parkinsoniens › Life style and Parkinson's disease.